Eli Lilly & Co. (LLY) thinks its next experimental weight-loss pill could get approved as soon as early 2026. CEO Dave Ricks ...

Nearly 200 Eli Lilly and Co. employees from the Lebanon site under construction volunteered to distribute 75,000 diapers to ...

Now that Novo Nordisk is the world’s weight-loss juggernaut, will it have to betray its first patients—type 1 diabetics?

EY—the professional services firm originally known as Ernst & Young—reports the dollar value of biopharma M&A deals nosedived ...

Though he'll forever be known as the COVID governor, here are some other key moments from Holcomb's eight years.

Two newly published water studies from the state predict that supply will continue to outpace demand for the vital resource ...

Though he'll forever be known as the COVID governor, here are some other key moments from Holcomb's eight years.

Lanphier's JaiQuan Holman netted 20 points in win over Rochester, plus other results around Springfield this week ...

Outgoing Governor Eric J. Holcomb and Indiana Secretary of Commerce David Rosenberg recently highlighted the 2024 economic ...

Eli Lilly's stock dipped due to cutting Q4 sales targets, despite a strong 2024 performance from Mounjaro and Zepbound. Click ...

Lilly’s decision to offer vials has also been seen as its way to combat the rise in compounding. Patients have been turning ...

Unfortunately for the company, however, the early glimpse at its fourth-quarter performance doesn’t seem to be going over ...